CASE STUDY increasing survival, free of bronchopulmonary dysplasia (BPD) in extremely preterm infants.
In 2025 the PLUSS Trial received the Australian Clinical Trials Alliance (ACTA) Trial of the Year Award as well as the ACTA STInG Excellence in Trial Statistics Award. youtu.be/FivYWQyp8m8
